欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4697/001
药品名称Strepfen Orange Sugar-Free 8.75mg Lozenge
活性成分
    • flurbiprofen 875.0 mg
剂型Lozenge
上市许可持有人Reckitt Benckiser Healthcare B.V. Siriusdreef 14 2132 WT Hoofddorp The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Strepfen zuigtabletten met sinaasappelsmaak Suikervrij 8,75 mg, zuigtabletten
互认成员国 - 产品名称
    • Austria (AT)
    • Cyprus (CY)
      Strefen Sugar Free lozenge 8,75 mg/loz
    • Spain (ES)
    • Czechia (CZ)
      Flurbiprofen Reckitt Benckiser 8,75 mg
    • Portugal (PT)
    • Romania (RO)
    • Greece (GR)
    • Slovakia (SK)
    • Sweden (SE)
    • Slovenia (SI)
    • Norway (NO)
    • Croatia (HR)
    • Finland (FI)
    • Germany (DE)
      Dobendan Direkt gegen Halsschmerzen
    • Poland (PL)
      Flurbiflex
    • Denmark (DK)
      Steflam Honning og Eukalyptus Sukkerfri
    • Latvia (LV)
      Strefen 8,75 mg sūkājamās tabletes
    • Belgium (BE)
      Strepflur 8,75 mg zuigtabletten
    • Estonia (EE)
      Strepfen Manuka Honey & Eucalyptus
    • Luxembourg (LU)
    • Hungary (HU)
    • Iceland (IS)
    • Bulgaria (BG)
      Strepsils intensive orange and mint sugar free
许可日期2021/09/29
最近更新日期2024/06/20
药物ATC编码
    • R02AX01 flurbiprofen
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Non Prescription (including OTC)
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase